X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2053) 2053
Publication (247) 247
Newsletter (162) 162
Book Review (35) 35
Newspaper Article (13) 13
Book Chapter (7) 7
Conference Proceeding (4) 4
Magazine Article (4) 4
Dissertation (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
itraconazole (1747) 1747
humans (1259) 1259
pharmacology & pharmacy (1012) 1012
male (802) 802
pharmacokinetics (719) 719
index medicus (683) 683
female (577) 577
adult (553) 553
antifungal agents - pharmacokinetics (477) 477
drug interactions (477) 477
antifungal agents - therapeutic use (435) 435
animals (432) 432
antifungal agents - administration & dosage (399) 399
fluconazole (392) 392
itraconazole - pharmacokinetics (360) 360
administration, oral (342) 342
antifungal agents - pharmacology (333) 333
middle aged (329) 329
itraconazole - administration & dosage (306) 306
voriconazole (294) 294
itraconazole - pharmacology (263) 263
itraconazole - therapeutic use (260) 260
microbiology (252) 252
antifungal agents (239) 239
area under curve (228) 228
amphotericin-b (222) 222
drugs (218) 218
ketoconazole (191) 191
metabolism (191) 191
antifungal agents - adverse effects (188) 188
cross-over studies (188) 188
research (188) 188
pharmacology (177) 177
aged (176) 176
antifungal agents - blood (176) 176
bioavailability (176) 176
infectious diseases (176) 176
in-vitro (170) 170
mycoses (166) 166
posaconazole (159) 159
biological availability (154) 154
adolescent (152) 152
rats (152) 152
itraconazole - blood (150) 150
analysis (149) 149
triazoles - pharmacokinetics (140) 140
terbinafine (139) 139
solubility (136) 136
mycoses - drug therapy (135) 135
aspergillosis (134) 134
dose-response relationship, drug (134) 134
treatment outcome (133) 133
therapy (128) 128
drug therapy (126) 126
fungal-infections (126) 126
pharmacodynamics (124) 124
microbial sensitivity tests (120) 120
half-life (116) 116
pharmacology/toxicology (116) 116
itraconazole - adverse effects (109) 109
double-blind method (108) 108
toxicology (107) 107
veterinary sciences (106) 106
itraconazole - chemistry (105) 105
safety (105) 105
aspergillosis - drug therapy (103) 103
cytochrome p-450 cyp3a (103) 103
mycology (103) 103
triazoles - therapeutic use (103) 103
triazoles - pharmacology (102) 102
p-glycoprotein (101) 101
young adult (97) 97
dermatology (96) 96
dosage and administration (96) 96
drug-interactions (96) 96
cytochrome p-450 (95) 95
health aspects (94) 94
antifungal (93) 93
triazoles - administration & dosage (93) 93
absorption (92) 92
dermatology & venereal diseases (91) 91
mice (91) 91
onychomycosis - drug therapy (91) 91
rats, sprague-dawley (91) 91
cytochrome p-450 enzyme system - metabolism (90) 90
onychomycosis (89) 89
drug administration schedule (86) 86
drug interaction (86) 86
efficacy (86) 86
invasive fungal-infections (85) 85
midazolam (84) 84
plasma (84) 84
child (83) 83
fungal infections (83) 83
inhibition (83) 83
ketoconazole - analogs & derivatives (83) 83
drug therapy, combination (82) 82
invasive aspergillosis (81) 81
mycoses - prevention & control (81) 81
cytochrome p-450 enzyme inhibitors (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2166) 2166
Japanese (26) 26
German (21) 21
French (17) 17
Spanish (6) 6
Chinese (1) 1
Dutch (1) 1
Finnish (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 07/2018, Volume 104, Issue 1, pp. 188 - 200
The accuracy of physiologically based pharmacokinetic (PBPK) model prediction in children, especially those younger than 2 years old, has not been... 
CLEARANCE | TISSUE DISTRIBUTION | IN-VIVO | VOLUME | ONTOGENY | PROTON PUMP INHIBITORS | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | SIMULATION | DESLORATADINE | EXPOSURE | Humans | Anti-Asthmatic Agents - metabolism | Child, Preschool | Cytochrome P-450 Enzyme System - metabolism | Sufentanil - metabolism | Bronchodilator Agents - metabolism | Quinolines - pharmacokinetics | Theophylline - pharmacokinetics | Esomeprazole - metabolism | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Ondansetron - metabolism | Child | Cytochrome P-450 CYP2C9 - metabolism | Histamine H1 Antagonists, Non-Sedating - pharmacokinetics | Infant, Newborn | Itraconazole - metabolism | Serotonin Antagonists - pharmacokinetics | Tramadol - pharmacokinetics | Theophylline - metabolism | Cytochrome P-450 CYP3A - metabolism | Models, Biological | Proton Pump Inhibitors - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Cytochrome P-450 CYP2D6 - metabolism | Serotonin Antagonists - metabolism | Analgesics, Opioid - metabolism | Diclofenac - metabolism | Lansoprazole - pharmacokinetics | Loratadine - pharmacokinetics | Sufentanil - pharmacokinetics | Infant | Anti-Asthmatic Agents - pharmacokinetics | Itraconazole - pharmacokinetics | Antifungal Agents - pharmacokinetics | Antifungal Agents - metabolism | Loratadine - metabolism | Cytochrome P-450 CYP2C8 - metabolism | Lansoprazole - metabolism | Acetates - metabolism | Esomeprazole - pharmacokinetics | Cytochrome P-450 CYP1A2 - metabolism | Ondansetron - pharmacokinetics | Tramadol - metabolism | Diclofenac - pharmacokinetics | Quinolines - metabolism | Pharmaceutical Preparations - metabolism | Proton Pump Inhibitors - pharmacokinetics | Bronchodilator Agents - pharmacokinetics | Analgesics, Opioid - pharmacokinetics | Cytochrome P-450 CYP2C19 - metabolism | Loratadine - analogs & derivatives | Histamine H1 Antagonists, Non-Sedating - metabolism | Pharmacokinetics | Acetates - pharmacokinetics
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 2004, Volume 94, Issue 9, pp. 1140 - 1146
Three-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors (statins) are first-line treatments for hypercholesterolemia. Although exceedingly well... 
CLARITHROMYCIN | INDUCED RHABDOMYOLYSIS | LOVASTATIN | CARDIAC & CARDIOVASCULAR SYSTEMS | CONCOMITANT USE | ERYTHROMYCIN | FATAL RHABDOMYOLYSIS | ITRACONAZOLE | ROSUVASTATIN | DRUG-INTERACTION | CYCLOSPORINE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pyrroles - pharmacokinetics | Cytochrome P-450 Enzyme Inhibitors | Cytochrome P-450 Enzyme System - administration & dosage | Area Under Curve | Heptanoic Acids - pharmacokinetics | Humans | Middle Aged | Mibefradil - pharmacokinetics | Male | Protein Synthesis Inhibitors - administration & dosage | Verapamil - administration & dosage | Dose-Response Relationship, Drug | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Antiprotozoal Agents - pharmacokinetics | Drug Interactions | Itraconazole - pharmacokinetics | Pyrroles - administration & dosage | Clarithromycin - pharmacokinetics | Mibefradil - administration & dosage | Clarithromycin - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Female | Itraconazole - administration & dosage | Drug Therapy, Combination | Double-Blind Method | Simvastatin - administration & dosage | Verapamil - pharmacokinetics | Biomarkers - blood | Simvastatin - pharmacokinetics | Protein Synthesis Inhibitors - pharmacokinetics | Atorvastatin Calcium | Anticholesteremic Agents - pharmacokinetics | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Adolescent | Antiprotozoal Agents - administration & dosage | Calcium Channel Blockers - administration & dosage | Creatine Kinase - drug effects | Calcium Channel Blockers - pharmacokinetics | Pravastatin - pharmacokinetics
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2018, Volume 84, Issue 1, pp. 52 - 63
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article
Journal of Veterinary Pharmacology and Therapeutics, ISSN 0140-7783, 01/2019, Volume 42, Issue 1, pp. 1 - 6
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 11/2008, Volume 48, Issue 11, pp. 1323 - 1338
This study investigated the potential pharmacokinetic interaction between the direct renin inhibitor aliskiren and modulators of P‐glycoprotein and cytochrome... 
direct renin inhibitor | P‐glycoprotein | Cytochrome P450 | drug interaction | P-glycoprotein | Direct renin inhibitor | Drug interaction | TRANSPORTER | VOLUNTEERS | PHARMACODYNAMICS | ITRACONAZOLE | CLINICAL PHARMACOKINETICS | IN-VITRO | PHARMACOLOGY & PHARMACY | ABSORPTION | 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONISTS | HYPERTENSION | DRUG-DRUG INTERACTIONS | Antifungal Agents - adverse effects | Digoxin - adverse effects | Pyrroles - pharmacokinetics | Heptanoic Acids - pharmacokinetics | Humans | Male | Heptanoic Acids - adverse effects | Organic Anion Transporters - metabolism | Tissue Distribution | Young Adult | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Drug Interactions | Antifungal Agents - pharmacokinetics | Amides - adverse effects | Amides - pharmacokinetics | Pyrroles - adverse effects | Adult | Female | Caco-2 Cells | Cell Line | Ketoconazole - pharmacokinetics | Fumarates - adverse effects | Digoxin - pharmacokinetics | ATP Binding Cassette Transporter, Subfamily B, Member 1 - antagonists & inhibitors | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Renin - antagonists & inhibitors | Cytochrome P-450 CYP3A - metabolism | Fumarates - pharmacokinetics | Atorvastatin | Ketoconazole - adverse effects | Antihypertensive drugs | Dosage and administration | Glycoproteins | Research | Drug interactions | Cytochrome P-450 | Index Medicus
Journal Article